Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent-Reference-Cited by-同舟云学术

Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent

Published:2017-09-05 Issue:9 Volume:12 Page:e0183457
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ogunniyi Abiodun D.^ORCID,Khazandi Manouchehr,Stevens Andrew J.,Sims Sarah K.,Page Stephen W.,Garg Sanjay,Venter Henrietta,Powell Andrew,White Karen,Petrovski Kiro R.,Laven-Law Geraldine,Tótoli Eliane G.,Salgado Hérida R.,Pi Hongfei,Coombs Geoffrey W.,Shinabarger Dean L.,Turnidge John D.,Paton James C.,McCluskey Adam,Trott Darren J.

Funder

Australian Research Council

National Health and Medical Research Council

National Health and Medical Research Council (AU)

University of South Australia and the Sansom Institute of Health Research

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference62 articles.

1. World Health Organization Media Centre; The top 10 causes of death: Fact sheet No 310. 2014.

2. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition;CJ Murray;Lancet,2015